Lilly's Zepbound approved for treatment of sleep apnea [m5lRrOo2v3I]

| 1h 28m 28s | Video has closed captioning.

Lilly's weight loss drug Zepbound is now the first medication to receive FDA approval for the treatment of sleep apnea. Sleep apnea, a disorder that causes people to briefly stop breathing while sleeping, affects 25 million Americans and 100 million people worldwide. FULL STORY | --------------------------------------------------- WISH-TV website | Follow us! Download the WISH-TV App | Subscribe to the WISH-TV Newsletter | Have a news tip? Email us at [email protected] #original keto pills #optimal keto plus acv gummies #gold diet pills

Aired: January 07, 2025

Rating: TV-14